The LD 500 Archives - Page 14 of 21

TuesdaySep 01, 2020 4:20 pm

Performant Financial Corp. (NASDAQ: PFMT) Starts Presentation at The LD 500

Performant Financial Corp. (NASDAQ: PFMT) helps government and commercial organizations enhance revenue and contain costs by preventing, identifying and recovering waste, improper payments and defaulted assets. Performant is a leading provider of these services in several industries, including health care, student loans and government. Performant has been providing recovery audit services for more than nine years to both commercial and government clients, including serving as a recovery auditor for the Centers for Medicare and Medicaid Services. Powered by a proprietary analytics platform and workflow technology, Performant also provides professional services related to the recovery effort, including reporting capabilities, support services,…

TuesdaySep 01, 2020 3:40 pm

SG Blocks Inc. (NASDAQ: SGBX) Starts Presentation at The LD 500

SG Blocks Inc. (NASDAQ: SGBX) is a premier innovator in advancing and promoting the use of code-engineered cargo shipping containers for safe and sustainable construction. The firm offers a product that exceeds many standard building code requirements. The company's product supports developers, architects, builders and owners in achieving greener construction, with faster execution and stronger buildings of higher value. Each project starts with GreenSteel(TM), the structural core and shell of an SG Blocks building, and is then customized to client specifications. For more information, visit the company's website at www.sgblocks.com About The LD 500 The LD 500 is the most…

TuesdaySep 01, 2020 3:20 pm

Salarius Pharmaceuticals Inc. (NASDAQ: SLRX) Starts Presentation at The LD 500

Salarius Pharmaceuticals Inc. (NASDAQ: SLRX) is a clinical-stage oncology company targeting cancers caused by dysregulated gene expression and developing treatments for patients that need them the most. Epigenetics refers to the regulatory system that affects gene expression. Salarius' lead candidate, seclidemstat, is currently in a Phase 1/2 clinical trial for relapsed/refractory Ewing sarcoma, for which it has received Fast Track Designation, Orphan Drug Designation and Rare Pediatric Disease Designation from the U.S. Food and Drug Administration. Salarius is also developing seclidemstat for several cancers with high unmet medical need, with a second Phase 1/2 clinical study in advanced solid tumors,…

TuesdaySep 01, 2020 3:20 pm

Biomerica Inc. (NASDAQ: BMRA) Starts Presentation at The LD 500

Biomerica Inc. (NASDAQ: BMRA) is a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. The company's products are designed to enhance the health and well-being of people, enable prevention and early detection of disease and reduce total health care costs. Biomerica primarily focuses on gastrointestinal and inflammatory diseases where the company has multiple diagnostic and therapeutic products in development. For more information, visit the company's website at www.biomerica.com About The…

TuesdaySep 01, 2020 3:20 pm

Quantum Computing Inc. (OTCQB: QUBT) Starts Presentation at The LD 500

Quantum Computing Inc. (OTCQB: QUBT) is focused on developing novel applications and solutions utilizing quantum and quantum-ready computing techniques to solve difficult problems in various industries. The company leverages its team of experts in finance, computing, security, mathematics and physics to develop commercial applications for industries and government agencies that will need quantum computing power to solve their most challenging problems. For more information, visit the company's website at www.quantumcomputinginc.com About The LD 500 The LD 500 is the most ambitious project in LD Micro's 14-year history of leading the micro-cap space as an independent resource. Investors will enjoy updates…

TuesdaySep 01, 2020 3:20 pm

AutoWeb Inc. (NASDAQ: AUTO) Starts Presentation at The LD 500

AutoWeb Inc. (NASDAQ: AUTO) is a robust digital marketing platform providing high quality consumer leads, clicks and associated marketing services to automotive dealers and manufacturers throughout the United States. The company also provides consumers with robust and original online automotive content to help them make informed car-buying decisions. AutoWeb pioneered the automotive internet in 1995 and has since helped tens of millions of automotive consumers research vehicles; connected thousands of dealers nationwide with motivated car buyers; and helped every major automaker successfully market its brand online. For more information, visit the company's website at www.autoweb.com About The LD 500 The…

TuesdaySep 01, 2020 3:00 pm

Delcath Systems Inc. (NASDAQ: DCTH) Starts Presentation at The LD 500

Delcath Systems Inc. (NASDAQ: DCTH) is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company's investigational product, melphalan hydrochloride for injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS), is designed to administer high-dose chemotherapy to the liver while minimizing systemic exposure and associated side effects. In addition to the Phase 3 FOCUS trial, the company has initiated a global Phase 3 clinical trial for intrahepatic cholangiocarcinoma (ICC) called 'The ALIGN Trial'. Delcath is also evaluating other forms of metastatic liver cancers. For more information, visit the company's website at www.delcath.com About…

TuesdaySep 01, 2020 3:00 pm

IMV Inc. (NASDAQ: IMV) (TSX: IMV) Starts Presentation at The LD 500

IMV Inc. (NASDAQ: IMV) (TSX: IMV) is a clinical-stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of cancer-targeted immunotherapies and vaccines based on the company's proprietary drug delivery platform. This patented technology leverages a novel mechanism of action that enables the programming of immune cells in vivo, which are aimed at generating powerful new synthetic therapeutic capabilities. IMV's lead candidate, DPX-Survivac, is a T-cell-activating immunotherapy that combines the utility of the platform with a target: survivin. IMV is…

TuesdaySep 01, 2020 3:00 pm

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Starts Presentation at The LD 500

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence, machine-learning company that transforms data into knowledge. AnalytixInsight's financial analytics platform, CapitalCube.com, algorithmically analyzes market price data and regulatory filings to create insightful, actionable narratives and research on approximately 50,000 global companies and North American ETFs, providing high-quality financial research and content for investors, information providers, finance portals and media. AnalytixInsight also designs and implements workforce optimization solutions for large global enterprises. AnalytixInsight holds a 49% interest in MarketWall, a developer of fintech solutions for financial institutions. For more information, visit the company's website at AnalytixInsight.com About The LD 500…

TuesdaySep 01, 2020 3:00 pm

Acer Therapeutics Inc. (NASDAQ: ACER) Starts Presentation at The LD 500

Acer Therapeutics Inc. (NASDAQ: ACER) is a pharmaceutical company focused on the acquisition, development and commercialization of treatments for rare and life-threatening diseases with significant unmet medical needs. Acer's pipeline includes four clinical-stage candidates. Acer's product candidates present a relatively de-risked profile, having one or more of a favorable safety profile, clinical proof-of-concept data, mechanistic differentiation and/or accelerated paths for development through specific programs and procedures established by the FDA. For more information, visit the company's website at www.acertx.com About The LD 500 The LD 500 is the most ambitious project in LD Micro's 14-year history of leading the micro-cap…